NCT02943655View on ClinicalTrials.gov

Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

October 10, 2020

Study Completion Date

February 10, 2021

Conditions
Improve Quality of LifeHeavy Menstrual Bleeding
Interventions
DRUG

combined contraceptive pills (microcept)

oral combined contraceptive once daily

DRUG

medroxyprogesterone acetate (progest)

oral 5 mg medroxyprogesterone acetate daily

DRUG

mefenamic acid (ponstan forte)

oral 500 mg mefenamic acid three times per day

Trial Locations (1)

002

Ahmed Abbas, Assiut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02943655 - Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause | Biotech Hunter | Biotech Hunter